Hongri Pharmaceutical: Net profit was 65.7148 million yuan in the first quarter, an increase of 8.93% year-on-year.

Red Sun Pharmaceutical announced that its revenue for the first quarter of 2026 was 1.13 billion yuan, a year-on-year decrease of 18.85%; net profit was 65.7148 million yuan, a year-on-year increase of 8.93%.